In summary, we have discovered a new potential mechanism for negatively regulating the expression level of FOXC2 in GC by YTHDF2, finding a reasonable mechanism for YTHDF2 to inhibit the proliferation, invasion, and migration of GC cells, and also finding new targets for the clinical treatment of GC. This evidence concerns the gene YTHDF2 and gastric cancer.